Luckys Pharma Lab Private Limited

BUDEFLO FORTE Keyhaler: Advanced Respiratory Therapy for Severe Asthma and COPD

BUDEFLO FORTE Keyhaler combines Budesonide I.P. 400 mcg and Formoterol Fumarate Dihydrate I.P. 12 mcg to provide a potent dual-action therapy for managing severe asthma and chronic obstructive pulmonary disease (COPD).

TROPIUM-LS Keyhaler: Dual Bronchodilator Therapy for Respiratory Relief

TROPIUM-LS Keyhaler combines Ipratropium Bromide 40 mcg and Levosalbutamol 100 mcg to provide effective relief from bronchospasms associated with asthma, chronic obstructive pulmonary disease (COPD), and other obstructive airway disorders. Ipratropium Bromide, a short-acting muscarinic antagonist (SAMA), works by relaxing airway muscles and reducing bronchial secretions, promoting better airflow. Levosalbutamol, a short-acting beta-agonist (SABA), provides rapid bronchodilation, relieving acute breathing difficulties and reducing airway resistance.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

BUDEFLO-G FORTE: Triple Therapy for Enhanced Respiratory Care

BUDEFLO-G FORTE, delivered through an advanced Keyhaler device, combines Glycopyrrolate 25 mcg, Formoterol 12 mcg, and Budesonide 400 mcg to provide superior management of severe asthma and chronic obstructive pulmonary disease (COPD). Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA), reducing airway constriction and improving airflow. Formoterol, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, offering quick relief from breathing difficulties. Budesonide, a powerful inhaled corticosteroid (ICS), reduces airway inflammation and prevents exacerbations. 

BUDEFLO-G FORTE: Triple Therapy for Enhanced Respiratory Care

BUDEFLO-G FORTE, delivered through an advanced Keyhaler device, combines Glycopyrrolate 25 mcg, Formoterol 12 mcg, and Budesonide 400 mcg to provide superior management of severe asthma and chronic obstructive pulmonary disease (COPD). Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA), reducing airway constriction and improving airflow. Formoterol, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, offering quick relief from breathing difficulties. Budesonide, a powerful inhaled corticosteroid (ICS), reduces airway inflammation and prevents exacerbations. 

FLOMATE 250 is a highly effective combination inhaler designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Each dose contains:

• Fluticasone Propionate 250 mcg, a potent inhaled corticosteroid that reduces airway inflammation, preventing asthma symptoms and improving lung function over time.
• Formoterol Fumarate Dihydrate 6 mcg, a long-acting beta-agonist (LABA) that relaxes the airway muscles, providing rapid and sustained relief from bronchospasm, wheezing, and breathlessness.

FLOMATE 250 Dose Counter contains Fluticasone Propionate I.P. 250 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, a highly effective combination therapy for managing asthma and chronic obstructive pulmonary disease (COPD).